D E P A R T M E N T S

Report From the President
Routing Out Indifference
By José M. Zuniga

In the News
IAPAC Commits to "Fast Action" in Face of Global Challenges
By Scott A. Wolfe

Perspective
Time to Move on HIV/AIDS Treatment and Care
By Bernhard Schwartländer and Joep M.A. Lange

Abstracts

In the Life
Claire Touchie

Say Anything

Heavy Lifting in Glasgow (Wherein HIV Researchers Uncrate Some Clydeside Surprises)
After a year of meetings rife with HIV treatment news, how much can you expect from the Glasgow congress? Plenty. Pharmacokinetic curiosities included d4T triphosphate in people taking AZT, and indinavir/ritonavir lite -- 400/100 mg twice a day. A clutch of clinic reports agreed that long responders are replacing nonresponders, while other studies showed how T-cell counts sway STI results. New drugs on the agenda included T-20, atazanavir, and amprenavir's prodrug.
By Mark Mascolini